Rx Redefined
Arroyo Grande, US · Founded 2017 · Delaware corporation · 6 known investors
Rx Redefined provides a platform and management services for DMEPOS (durable medical equipment, prosthetics, orthotics, and supplies) ordering, handling revenue cycle processes, compliance checks, and audit processing for physicians. It integrates with existing EMR systems and reviews billing requirements, patient eligibility, and regulatory adherence for each physician order.
Founders & leadership
Rx Redefined was founded in 2017 by Brandon Boots.
BB
Brandon BootsFounder & CEO
ES
Erik SmithNamed on SEC filing
Board
IC
RC
Investors · 6
Funding
SEC filings, press & company announcements$35.7M disclosed across 4 of 5 rounds · 2021–2024
- Undisclosed amountSeries AAug 2023Source ↗
▶$21.5MraisedDec 2024 · 8 investors · OtherRule 506(b)
▶$21.5MraisedDec 2024 · 8 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Brandon BootsExecutive Officer, Director, Promoter
- Ian ChiangDirector
- Roger ChenDirector
- Erik SmithExecutive Officer, Director
- Offering amount
- $24M
- Amount sold
- $21.5M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8MraisedSep 2022 · 8 investors · Other Health CareRule 506(b)
▶$8MraisedSep 2022 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Erik SmithDirector
- Brandon BootsExecutive Officer
- Roger ChenDirector
- Offering amount
- $8M
- Amount sold
- $8M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$3MraisedJun 2021 · 6 investors · PharmaceuticalsRule 506(b)
▶$3MraisedJun 2021 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Roger ChenDirector
- Erik SmithExecutive Officer, Director
- Brandon BootsExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$3.2MraisedJun 2021 · 6 investors · PharmaceuticalsRule 506(b)
▶$3.2MraisedJun 2021 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Brandon BootsExecutive Officer, Director
- Roger ChenDirector
- Erik SmithExecutive Officer, Director
- Offering amount
- $3.2M
- Amount sold
- $3.2M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapRedsail Technologies5 shared keywordsRedSail Technologies develops pharmacy management software and clinical programs for community, long-term care, outpatient, and pharma customers. Its integrated tools aim to improve patient engagement, medication adherence, and health outcomes in the pharmacy industry.
Arrive Health4 shared keywordsArrive Health provides technology that surfaces real-time, patient-specific clinical, cost, and coverage data within electronic health record (EHR) and clinical workflows, helping providers and patients understand out-of-pocket treatment costs and make care decisions. It serves healthcare providers, care teams, and patients in the United States, and is now part of Interra Health.
RIS Rx4 shared keywordsRIS builds a pharmacist-driven platform for pharmaceutical manufacturers to detect and prevent gross-to-net (GTN) revenue leakage, copay misuse, and fraud through real-time claim adjudication and audits. It offers copay program management and reimbursement tools aimed at protecting drug-brand revenue while keeping patients on therapy.
RxVantage4 shared keywordsPlatform connecting healthcare providers with life science experts to access critical information and insights.
Companies competing with Rx Redefined for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Rx Redefined do?
- Rx Redefined provides a platform and management services for DMEPOS (durable medical equipment, prosthetics, orthotics, and supplies) ordering, handling revenue cycle processes, compliance checks, and audit processing for physicians. It integrates with existing EMR systems and reviews billing requirements, patient eligibility, and regulatory adherence for each physician order.
- Who founded Rx Redefined?
- Rx Redefined was founded by Brandon Boots in 2017.
- Who are Rx Redefined's investors?
- Rx Redefined's investors include Crosscut Ventures, Flare Capital Partners, Silverton Partners, Hatteras Venture Partners, Saturn Five, Tusk Venture Partners.
- How much funding has Rx Redefined raised?
- Rx Redefined has disclosed $35.7M raised across 4 of its 5 known rounds.
- Where is Rx Redefined headquartered?
- Rx Redefined is headquartered in Arroyo Grande, US.